INS and metabolic dysfunction-associated steatotic liver disease: Emerging as key mediators in the pathophysiology of MASLD, adipokines and hepatokines—secreted by adipose tissue and liver, respectively—have influenced insulin sensitivity, inflammation, and fibrogenesis [8,9].